Trending...
- Attorney Joseph C. Kreps Files Lawsuit to Stop Alabama State Board of Pharmacy's Unlawful "Revenue-First" Rulemaking
- Forge Resources Unlocks Major Gold-Copper System in Yukon as Drilling Success and Strategic Assets Fuel High-Impact Growth Story for: $FRGGF
- NAIDOC Week Australia 2026 | 50 Years Deadly - Celebrates Culture, Resilience, and Global Connection
~ In a groundbreaking move, the Tacoma City Council has passed Resolution 41609, declaring entheogen-related activities as the lowest law enforcement priority within the city. The resolution, which was brought forward by District 5 Council Member Joe Bushnell and co-sponsored by Mayor Victoria Woodards, At-large Council Member Olgy Diaz, and District 3 Council Member Jamika Scott, aims to open doors for mental health treatment research by decriminalizing entheogens.
Council Member Bushnell, a veteran who lives with PTSD, emphasized the importance of exploring innovative and compassionate approaches to mental health. He stated that in the United States alone, 22 veterans commit suicide every day and as someone who understands the challenges of living with a mental health condition, he sees the potential of entheogens as a beacon of hope. By declaring support for decriminalization, Tacoma can advocate for further research and potentially life-changing treatments.
More on Washingtoner
Entheogens have been scientifically proven to be effective in treating various conditions such as depression, anxiety, addiction, and PTSD. In fact, the FDA has designated psilocybin-assisted therapy as a breakthrough treatment for treatment-resistant depression.
Tacoma now joins other Washington state jurisdictions such as Seattle, Port Townsend, Olympia, and Jefferson County in deprioritizing local enforcement against entheogen-related activities. This move reflects a growing trend towards recognizing the potential benefits of these substances in treating mental health conditions.
The passing of Resolution 41609 is seen as a significant step towards promoting more progressive and compassionate approaches to mental health treatment in Tacoma. With this resolution in place, it is hoped that further research will be conducted on entheogens and their potential therapeutic uses.
Council Member Bushnell, a veteran who lives with PTSD, emphasized the importance of exploring innovative and compassionate approaches to mental health. He stated that in the United States alone, 22 veterans commit suicide every day and as someone who understands the challenges of living with a mental health condition, he sees the potential of entheogens as a beacon of hope. By declaring support for decriminalization, Tacoma can advocate for further research and potentially life-changing treatments.
More on Washingtoner
- Captain Notepad Expands Free Custom Design Services Across Full Product Line
- Sycor Introduces Spring Release 2026 of Sycor.Rental with AI-Driven Innovations and Enhanced Service Processes
- YOKE Expands NIL Club Into Athlete-Led Commerce With Athlete Merch Launch
- Floor Kings Announces Official Launch of Premier Epoxy Flooring Services Across Arizona
- UK Buyers Purchase Luxury Home in Keene's Pointe, Windermere (Orlando, Florida)
Entheogens have been scientifically proven to be effective in treating various conditions such as depression, anxiety, addiction, and PTSD. In fact, the FDA has designated psilocybin-assisted therapy as a breakthrough treatment for treatment-resistant depression.
Tacoma now joins other Washington state jurisdictions such as Seattle, Port Townsend, Olympia, and Jefferson County in deprioritizing local enforcement against entheogen-related activities. This move reflects a growing trend towards recognizing the potential benefits of these substances in treating mental health conditions.
The passing of Resolution 41609 is seen as a significant step towards promoting more progressive and compassionate approaches to mental health treatment in Tacoma. With this resolution in place, it is hoped that further research will be conducted on entheogens and their potential therapeutic uses.
0 Comments
Latest on Washingtoner
- This Saturday: Open House for Manalapan's Newest Single Family Home Community
- Radarsign™ Awarded Sourcewell Contract Expanding Access to Traffic Safety Solutions
- MainConcept and NETINT Bring VPU Acceleration to Easy Video API
- City Of Spokane Partners With Meals On Wheels To Purchase Cooling Fans For Local Seniors, Residents With Disabilities
- Larry R. Wasion's Jump Gate 2: Teleporter Expands the Time Travel Universe with High-Stakes Action and Ethical Dilemmas
- Bruce A. Rosenblat Releases A Pocket Full of Change, a Sharp, Thought-Provoking Book on Growth, Perspective, and Personal Change
- Marcus Boyd Announces Upcoming Children's Book The Royal World of Autism and Expands His Global Advocacy for Autism Awareness
- Phuket Bike Week Rebrands as Hard Rock Cafe Phuket Bike Week Under Landmark 5-Year Partnership
- Haven Treatment Center to Attend Shared Hope International Training Event in Vancouver
- L2 Aviation Appoints Tony Bailey as President and Chief Operating Officer
- Spokane: City Council Hosts Community Day Celebrating Disability And Accessibility Community
- Pieter Bouterse Studio Founder to Retire After 40+ Years; Seeks Successor to Continue Legacy
- #WeAreGreekWarriors Opening Reception Packs the House
- Tacoma Police Department's CALEA Public Comment Portal
- Mensa Brings National Board Game Competition to Northern Virginia April 16-19
- Special Alert! Highly Undervalued Stock: $317M Revenue in 2025 for Telecom Leader IQSTEL, Inc. (N A S D A Q: IQST)
- Igniting High-Growth Transformation With Launch of XMax AI Subsidiary, Leveraging Global Furniture Dominance to Enter Explosive AI Markets: XMax Inc
- Acuvance Earns 2026 Great Place to Work® Certification
- As Global Tensions Rise, Demand Grows for Private Spaces to Process Thoughts and Speak Freely Online
- Two Porch Fires Displace Eleven Residents in Spokane